Medicine and Dentistry
Chronic Kidney Disease
100%
Human Immunodeficiency Virus
26%
Follow up
26%
Glomerular Filtration Rate
26%
Lopinavir/Ritonavir
20%
Number Needed to Harm
20%
Atazanavir Plus Ritonavir
20%
Human Immunodeficiency Virus Infection
13%
Development
13%
Proteinase Inhibitor
13%
Tenofovir
13%
Incidence
13%
Morbidity
6%
Drug Use
6%
Senescence
6%
Hypertension
6%
Decision Making
6%
Cardiovascular Disease
6%
Adverse Event
6%
Hepatitis C
6%
High Risk Population
6%
Proteinuria
6%
Mixed Infection
6%
Low Risk Population
6%
Drug
6%
Chemotherapeutic Agent
6%
Mortality
6%
Atazanavir
6%
Arm
6%
Therapeutic Procedure
6%
Gender
6%
Race
6%
Person
6%
Clinician
6%
Health
6%
Female
6%
Patient
6%
Hospital
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
HIV
26%
Lopinavir Plus Ritonavir
20%
Number Needed to Harm
20%
Atazanavir Plus Ritonavir
20%
Human Immunodeficiency Virus Infection
13%
Proteinase Inhibitor
13%
Tenofovir
13%
Anti-Human Immunodeficiency Virus
13%
Incidence
13%
Hypertension
6%
Adverse Event
6%
Morbidity
6%
Diabetes Mellitus
6%
Proteinuria
6%
Hepatitis C
6%
Drug
6%
Mixed Infection
6%
Mortality
6%
Atazanavir
6%